Application
Benchling & Jounce Therapeutics: Migrating to an All-in-One Cloud Solution Saves Time on Data Management
Benchling
Aug 24, 2021
Abstract
Jounce Therapeutics uses a number of different analytical techniques to identify biomarkers in the tumor microenvironment (TME) that can help them match their drug candidates with the right patients. But they needed a way to manage all their assay and antibody data from concept to IND across different teams. Learn how Benchling unified Jounce's digital infrastructure to improve productivity and collaboration, and achieve a 100% software adoption rate.
Application File
Benchling & Jounce Case Study.pdf
Premier Sponsor
Latest Protocols
- Zebrafish Tumor Graft Transplantation to Grow Tumors In Vivo That Engraft Poorly as Single Cell Suspensions
- An Automated Low-Cost Swim Tunnel for Measuring Swimming Performance in Fish
- A Rabbit Femoral Condyle Defect Model for Assessment of Osteochondral Tissue Regeneration
- Cartilage Assessment Requires a Surface Characterization Protocol: Roughness, Friction, and Function
Comments
Be the first to comment.